knowledge -WSS

knowledge

author：explore 2025-10-01 05:40:15 - browse：6

Is biotech back from its downturn? Can Nvidia solve biology? And is it wise to do a deal on a party bus?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Recording from the J.P. Morgan Healthcare Conference, we discuss how a spate of deals and some intermittent sunshine seem to have brightened the outlook for biotech at the outset of 2024. We also talk about the latest twist in the Sarepta Therapeutics saga, a ubiquitous dealmaker, and life on the party circuit.

For more on what we cover, here’s the news on Sarepta; here’s more on Nvidia; here’s the story on Centerview; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Peter Hotez and the public health issue of online harassment
Next article： Maisha Meds is a PBM, but don't call it that

entertainment

WSS

As Taiwan prepares for anti

Hyaluronic acid injections don’t help knee osteoarthritis, study finds

What causes osteoarthritis? Researchers study link to brain protein

Maisha Meds is a PBM, but don't call it that

Readout Newsletter: Parkinson's study, Gilead, CG Oncology

7 of the most gruesome medical devices in history

hotspot

knowledge

focus

The high cost of giving birth even with insurance

Providers still hesitate to prescribe buprenorphine, study finds

The cancer drug shortage isn’t new — and neither are the solutions

Update the Apgar Score to remove skin color

Affirmative action in medical school literally saved lives

What to know about Saharan dust affecting the US and how it can affect health

Dobbs anniversary: the lost opportunity of abortion as health care

High breast density mammograms need follow

At least 13 dead in Texas as scorching temps continue

Court strikes down limits on filming of police in Arizona

explore

High breast density mammograms need follow

Readout Newsletter: Parkinson's study, Gilead, CG Oncology

FDA official pushes for dedicated emerging pathogens team

AbbVie dramatically boosts its spending on lobbying

Microsoft launches AI tool for clinical documentation through Epic

Caitlin Bernard's story shows physicians can't shy from advocacy

hotspot

entertainment

hotspot

explore